ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 113 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $26,559,000 | +1.5% | 650,000 | 0.0% | 0.52% | -8.1% |
| Q1 2021 | $26,169,000 | -30.3% | 650,000 | +2.4% | 0.57% | -28.3% |
| Q4 2020 | $37,548,000 | +21.6% | 635,000 | 0.0% | 0.80% | +1.5% |
| Q3 2020 | $30,880,000 | +11.0% | 635,000 | +10.4% | 0.78% | +2.8% |
| Q2 2020 | $27,819,000 | +83.7% | 575,000 | +5.5% | 0.76% | +21.9% |
| Q1 2020 | $15,140,000 | -7.2% | 545,000 | 0.0% | 0.63% | +21.6% |
| Q4 2019 | $16,306,000 | -3.2% | 545,000 | 0.0% | 0.52% | -23.2% |
| Q3 2019 | $16,841,000 | -41.9% | 545,000 | -9.2% | 0.67% | -36.0% |
| Q2 2019 | $28,980,000 | – | 600,000 | – | 1.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,030,434 | $23,152,516 | 15.55% |
| BERYLSON CAPITAL PARTNERS, LLC | 289,726 | $2,213,507 | 6.45% |
| Matrix Capital Management Company, LP | 11,572,590 | $88,414,588 | 1.69% |
| Pier Capital, LLC | 1,012,401 | $7,734,744 | 1.27% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $229,151,929 | 1.15% |
| Eagle Health Investments LP | 607,860 | $4,644,050 | 1.07% |
| Triatomic Management LP | 130,805 | $999,350 | 0.84% |
| Aristotle Atlantic Partners, LLC | 1,880,567 | $14,367,532 | 0.80% |
| Senator Investment Group LP | 1,000,000 | $7,640,000 | 0.69% |
| ARK Investment Management | 9,201,245 | $70,297,512 | 0.61% |